A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


November 5, 2012

Methadone Linked to Drop in HIV Rates Among Injection Drug Users

A major research review has found that injection drug users (IDUs) on methadone treatment are 54 percent less likely to contract HIV, according to a study published in the online edition of the British journal BMJ and reported in The New York Times.

The study was conducted by a group of researchers from the United Kingdom, Italy, the United States, Canada and Australia. The consortium analyzed a dozen published studies with information concerning opiate replacement therapy’s impact on HIV transmission; pooling data from nine of these studies, researchers identified 819 HIV infections spanning 23,000 person years.

The scientists suggested that the dramatic risk reduction was due to the fact that methadone improved drug users’ ability to adhere to HIV medications—which in turn reduced their likelihood of infecting others—and to refrain from sharing needles or from exchanging sex for drugs. However, given that those who commit to methadone treatment may also be more motivated toward risk-reducing behaviors, methadone on its own may not be the full cause of the 54 percent reduction.

The findings are vital, however, for efforts to push for opiate-replacement programs in countries such as Russia where injection drug use is rampant and is a major driver of new HIV infections, but where methadone remains illegal.

For the New York Times story, click here.

For a PDF of the research paper, click here.

Search: HIV, methadone, opiate replacement therapy, drop in infection rates, injection drug users, IDU, BMJ, The New York Times

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.